MedNet is proud to partner with leading Clinical Research Organizations (CROs) and healthcare consultants from around the world through the iMedNet Partner Program. All Partners have demonstrated expertise in configuring studies within the iMedNet environment and have certified iMedNet Designers on staff who are fully trained on the capabilities of the iMedNet eClinical solution.
Life science companies that are looking for trusted experts to help them with iMedNet system design, testing and deployment need look no further than our iMedNet Partners. These organizations can provide a wide range of value-added services, from standalone iMedNet eClinical design and validation services to more comprehensive solutions that couple their specific clinical research services with MedNet’s highly efficient and user-friendly iMedNet platform.
CROs and Consultants Discuss the Benefits of Working with MedNet
Current Partners Include:
Headquartered in Rockville, Maryland, Accelovance is a privately held company that has developed a unique operational approach for delivering quality, on time, and cost effective clinical studies. The company was recognized as “Best CRO” with consecutive Industry Excellence awards in 2009, 2010 and 2011. Accelovance tailors its full offering of CRO services to present a clinical solution that meets a sponsor’s needs. Accelovance has a 100% owned subsidiary providing CRO services in China. These capabilities can assist clients with global development programs or product registration in China, the fastest growing pharmaceutical market in the world.
Founded in 1996, Advance Research Associates has been a trusted clinical research partner (CRO) to the pharmaceutical, biotech, and medical device industries for over fifteen years. In the years since its inception, ARA has provided a spectrum of innovative solutions and has lent its expertise in data management and biostatistics across a wide range of projects for all study phases. ARA works as an extension of the client team, ensuring that clinical study timelines, costs, and project requirements are met. As a CRO for over 150 companies and having supported over 350 studies, ARA prides itself on delivering a high-quality product that has led to 70% of our business coming from repeat clients.
Chiltern is the leading, global mid-sized contract research organization. We listen to client needs to deliver customized clinical development solutions with a team of more than 4,000 working across 47 countries to provide comprehensive, yet flexible and responsive, services with specialties in clinical development, oncology, device & diagnostics, data, analytics & evaluation and strategic service provision.
Clinlogix is a global clinical research organization that delivers individualized clinical research solutions to the medical device and biopharmaceutical industries. Its full suite of services supports clinical development of medical devices, pharmaceuticals, biologics and diagnostics from early feasibility/discovery through first-in-human, pivotal and post-market clinical studies. The company has broad expertise addressing regional and worldwide regulatory requirements through its headquarters in Spring House, PA., and satellite offices in the UK, Germany and Latin America.
EMB Statistical Solutions, LLC is a niche CRO specializing in the Data Management and Statistical Analysis/Reporting of clinical research data. EMB has a dedicated team of senior level biostatisticians, statistical programmers and data managers with a company average of more than 20 years of industry experience. EMB has established a record of success with its team approach – where each team member follows a project to its successful completion. With ZERO turnover since forming in 2000, our clients receive consistent, reliable and fast results and benefit from direct contact with EMB experts..
Since 1992, Health Policy Associates (HPA, Inc.) has been providing high quality consulting services to the medical biotechnology community. HPA serves its clients on an exclusive basis in the areas of product development, regulatory/clinical consulting, strategic planning, clinical operations, operational staffing, and venture financing. HPA accomplishes this by providing a personal, adaptable, and comprehensive approach to solving complex problems on multiple levels. HPA is highly specialized in bringing the best product development, regulatory, and clinically focused strategic thinking in the industry to clients throughout the world.
IND 2 Results (I2R) is a full-service CRO that provides IND support and full clinical trial management services to start-up and small biopharmaceutical companies. We have established a multi-disciplinary team of experienced clinical trialists who work with our clients to ensure their success. I2R leverages best in class technologies such as EDC, eIND Submissions, cloud-based project environments, and other software tools to make the clinical trial process more efficient and gather data more quickly.
L3 Clinical Trials, a full-service Clinical Research Organization (CRO) and division of L3 Healthcare, specializes in in vitro diagnostics (IVD) and medical devices. By engaging with L3, you will quickly see the value of our clinical research services, which includes comprehensive trial and data management, site resources and an experienced team. We use our expertise and right-sized business model to help accelerate the design and execution of cost-effective FDA and ICH compliant trials. Ultimately, our goal is to not only ensure you have clinical data that gains regulatory acceptance, but data that also maximizes clinical adoption of your novel technology in the market.
NAMSA has provided services to medical device manufacturers for 45 years, specializing in material safety testing and consulting. Through acquisition, NAMSA added comprehensive regulatory and quality systems support, expanded functional studies with state of the art imaging capabilities, full clinical research services with contract field clinical engineers, and expanded educational services including physician and sales training. NAMSA continues to enhance medical product development by guiding inventors and manufacturers on the most efficient path to commercialization.
Qmed Consulting offers strategic consulting services based on best-in-class knowledge, experience and competences from a result-oriented and highly motivated team of international medical device strategic advisors, CRO specialists and commercial healthcare experts. Our purpose is to be part of the team that successfully paves the way for new medical device approvals that enable more efficient procedures while improving patient safety, outcomes and quality of life, thus helping inventors and investors achieve success. We help create success for our clients based on international best practices, close personal collaboration, and device approval solutions that serve their best interests.
Statistics & Data Corporation (SDC) provides innovative biostatistics and clinical data management services to pharmaceutical, biotechnology, and medical device companies, as well as CRO partners. SDC is committed to providing experienced teams who take ownership of deliverables and provide positive engagement on projects. SDC delivered on-time on over 99% of key project milestones since 2010, and has a proven track record for rapidly delivering analyses during project closeout (consistently providing top-line analysis within 3 business days of database lock).
SPIRITT is a specialty clinical research team focused on collecting high-quality patient-informed evidence in the medical device, biologic and pharmaceutical industries. SPIRITT Research offers full or a la carte services for medical practices (community-based and academic) and industry sponsors, including: clinical study development and execution services; subject engagement and compliance; regulatory guidance; product development; educational training/support services; abstract preparation/podium presentation assistance and peer-reviewed journal publication assistance.